key: cord-0806316-zfxr0li4
authors: Rawlings, Stephen A; Scott, Brianna; Layman, Laura; Naranatt, Pramod; Heltsley, Roy; Ignacio, Caroline; Porrachia, Magali; Gianella, Sara; Smith, Davey; Chaillon, Antoine
title: Can’t Work from Home: Pooled Nucleic Acid Testing of Laboratory Workers During The COVID-19 Pandemic
date: 2021-03-15
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofab129
sha: e626d28cbf3496944fe531d397b03fa36f5e1394
doc_id: 806316
cord_uid: zfxr0li4

Together with protective measures, routine screening for SARS-CoV-2 infection help provide a safe working environment. We evaluated a pooled nucleic acid testing strategy in a research laboratory. It allowed to maintain its activity and would save 25,920 person-hours and $1,684,800/year by increasing the margin of safety for returning to work.

Many businesses across the United States (US) have temporarily closed down to help reduce surges in hospitalizations 1 . As the US economy restarts, methods must be developed to protect employees in the workplace. This includes biomedical laboratories working on SARS-CoV-2, as one infected employee could cause the entire lab to be shut down for weeks. This is because all employees in contact with the index case may need to be quarantined for at least two weeks. The process of quarantining after potential exposure can also reduce workforce capacity in essential service settings, such as hospitals, clinics, police, and fire departments. Regular screening could theoretically decrease the risk of workplace infections, but individual tests are in short supply, costly, and not always performed in real-time to ascertain asymptomatic infections and thus impact viral spread.

A pooling strategy could represent a solution to the testing supply issue because biological specimens from multiple persons are combined into a testing pool and tested via a single test. This is also a cost-effective approach for routine screening of a population where suspicion of a positive is very low. A similar approach has been used to the monitoring of persons with HIV 2 . Pooling approaches for SARS-CoV-2 screening began to be granted emergency use authorization from the US FDA in July of 2020 3 . Pooling approaches generally have used pools of 4 samples based on initial guidance by the FDA 4,5 , but pools as large as 10-15 have also been assessed 6, 7 .

This study evaluated pooled nucleic acid testing (NAT) strategies to screen for SARS-CoV-2 infection in laboratory employees. Such pooled NAT strategies have been used for screening for acute HIV across communities 8 and in blood donors for HIV and HCV 9 . This pooled NAT strategy was implemented in a new point-of-care, low complexity NAT platform (Fluxergy Inc., Irvine, CA).

The study was conducted under a protocol for collecting samples from persons with known or possible SARS-CoV-2 infection approved by the Institutional Review Board of the University of California San Diego (UCSD). Written informed consent was obtained from all participants involved in the study. Laboratory employees had the option to enroll in the study but were not required to participate.

A c c e p t e d M a n u s c r i p t

The study took place in an academic virology laboratory at UCSD. Participants in the study were offered the choice to perform their own anterior nasal swab (self-swabbing) or have an anterior nasal swab collected by an on-site physician.

The Fluxergy platform was evaluated in the lab by comparing results with the RT-PCR Diagnostic Panel authorized for Emergency Use Authorization. 10 The limit of detection was also evaluated prior to the study and was estimated to be 2.4 copies/L (supplementary materials). Swabbing was offered to all laboratory research personnel between April 9 and Dec 22, 2020. The sampling and testing protocol was designed as follows (Figure 1 ).

1. Nasal swabs were collected on a daily basis for all eligible participants at the beginning of their respective shift, (two daily shifts). Polyester flocked swabs were used in all nasal swabs (COPAN, Murrieta,CA).

2. After collection, the nasal swabs were placed in 3mL of viral transport media (VTM). 5. If a mini pool test was positive, all samples from that pool were tested individually. 6 . Experimental pools were also evaluated to determine how many samples could be pooled together to identify a positive nasal swab in the pool.

On Day 1 (April 9 th ), a laboratory technician reported that a member of their household tested positive for SARS-CoV-2 infection. This index case was asymptomatic at the time. All seven members of the laboratory at work that day, including the index case, volunteered for screening for SARS-CoV-2 infection by individual and pooled NAT. The mini pool of 7 nasal swab samples was found to be positive within an hour of swabbing, and individual testing of each specimen confirmed positivity for only one sample while a mini pool of 6 without the A c c e p t e d M a n u s c r i p t index case was negative. The index case was sent home to follow-up with their primary care provider and for self-isolation.

Lab workers reported overall satisfaction with routine self swabbing because it increased the margin of safety for returning to work and thus the program of swabbing and pooling continued. From April 9 to Dec 22, the program was expanded to 18 essential staff in the lab who self swabbed a median of 3 [95%I:1-10] times per week. Pools were regularly scheduled throughout the week (usually Monday, Wednesday, and Friday) and offered in the morning and afternoon to capture two shifts throughout the day. Results were routinely available 1.5 -2 hours after the start of a shift. Pools were limited to 10 swabs maximum in order to maintain sensitivity, but average pool size was 6 (range 2 -10). A median of 40 tests per week [95%I: 13-105] were performed (Figure 2) . The essential staff members were tested a median 90 times [95%I:34-122] in the 37-week period. Of the 237 pools, 15 (6%, n=96 samples) were considered positive but upon deconvolution, all but the very first pool (on April 9) were determined to be false positives. This information was used to optimized the testing platform, which was still investigational at the time of use. False positives were defined as a pool that was positive on initial testing but no positive was identified on deconvolution. As deconvolution could be done in 1-2 hours, no initial steps were taken to send employees home during this testing as routine measures such as masking and physical distancing were also in place.

To evaluate the sensitivity of the pooling strategy, we additionally performed an experimental pooling of 30 stored samples collected during the study period, including one sample from the index case. Evaluation of pool sizes found that this positive sample from the index case could be detected up to a pool size of 30 samples. As mentioned above, though, pools were limited in size to 10 for both practical (not usually more than 10 employees per shift) and test sensitivity purposes.

When testing is not widely available, the CDC currently recommends that all potentially here assume either that the individuals furloughed by 75% would not be paid for work they did not do or that the employer would continue to pay that 75% but not otherwise have that productivity due to furlough.

As the world's economies seek to re-open and reduce shelter-in-place measures, testing for asymptomatic and presymptomatic carriers will be a critical step for employees in the workplace 13 . Testing, however, can be cost-prohibitive, especially when used for frequent screening of a population with a low incidence of infection. For this reason, pooling of samples from all persons who will be working together can provide a sensitive and costefficient method of detecting virus shedding within a work environment. This study found that, in an academic virology laboratory, pooled NAT was acceptable to laboratory employees, and that it could save ~ $86,000 in laboratory wages in the situation of a single asymptomatic case that would otherwise require 17 individuals to quarantine for 14 days.

Importantly, this calculation is based on the guidelines that were place at the time (April 2020), but quarantine guidelines are updated regularly and savings could depend on the worker type (e.g. health care worker vs. teacher) as well as clinical situation (e.g. where individuals have been vaccinated and are no longer required to quarantine). Additionally, some workplaces are reducing worker density as a precaution, but where working in-person is essential (such as a research laboratory), using daily, pooled, testing to increase the safety margin for working may permit 100% capacity. While there is a cost to this testing, the A c c e p t e d M a n u s c r i p t use of pooling dramatically reduces that cost and is minimal compared to lost wages should work not be done at 100% density. Importantly, we did not rely on testing alone as the only means to reduce spread of SARS-CoV-2 in our workplace and would encourage others to use a multi-layered approach as well. Our university still required-and our work environment complied with-minimum of 6foot distancing, mask wearing whenever individuals were not eating or at their desk, mandatory symptom screening, and frequent disinfection of surfaces. We consider the testing protocol described here to be an additional layer of protection. We also took very seriously privacy in the workplace and to the best of our ability limited information about test results and who was or was not testing. All participants were assigned study IDs and only the two study physicians (SAR and DS) had access to the names of participants. While there is always room for employees to assume someone was positive based on their absence or determine which individuals are in a pool based on who is present for a particular shift; we did not publicly release any test results. When pools were negative, a general announcement in the work area that the morning or afternoon pool was negative would be made, but otherwise no effort was made to single out individuals in a pool to tell them they were negative. The lab did not require testing as a pre-requisite to work and we believe the evidence that the employees saw it as truly optional is in the wide range of tests per participant (95%: 34-122 times in the 37-week period of the study). Clearly, some participants opted to test roughly once per week while others tested nearly every time a pool was being constructed.

Based on this small study, true risk reduction in workplace infection could not be ascertained or generalized to other settings. Further, while the Fluxergy platform was used in this study, other NAT platforms could also be used, but their test characteristics would need to be evaluated. Limitations of the study include that there was-thankfully-only one true positive case. As mentioned above, we used viral transport media from the positive case to internally validate that a positive could be detected amongst up to 29 negatives (i.e. a total pool size of 30). The sensitivity of a pooling approach in a group setting such as a workplace is governed by three principles: 1) the viral load of any particular infected individual when sampling is done, 2) the consistency with which swabs are performed to collect nasal/nasopharyngeal secretions, and 3) the chance of diluting out (via pooling) any viral RNA collected by a swab below the limit of detection of the machine-which, at this limit, is governed by Poisson distribution dynamics. We felt that through frequent testing (e.g. every 1-3 days) we were more likely to capture days when an asymptomatic infection is positive and repetition of selfswabbing was likely to increase reliability of swabbing via familiarization. Even though swabbing by an on-site physician was offered, all participants opted to self-swab after the A c c e p t e d M a n u s c r i p t first 1-2 swabs. Finally, because we limited our pools to 10 swabs-but had data that a single positive in pools 3 times larger could still be detected-we felt the loss of sensitivity due to pooling did not affect the results.

With current testing supplies limited, the pooling of samples from persons who work together or are otherwise in close proximity offers a cost-efficient way to increase the surveillance of a population while enabling progressive deconfinement. In a real work, prospective setting, this study validated a fast, sensitive, and efficient platform for routine testing of SARS-CoV-2

infection. This approach could be applied in other settings to help ensure a safe return to work procedures. It could be envisioned in high-risk settings such as screening of all healthcare workers in cancer or HIV clinic or nursing home, or screening essential personnel in police or fire departments. M a n u s c r i p t 

World Health Organization, W. Coronavirus disease 2019 (COVID-19) Situation Report -98. (World Health Organization

The use of pooled viral load testing to identify antiretroviral treatment failure

Journal of clinical virology : the official publication of the Pan American Society for

Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals

Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling

Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2

Detection of acute infections during HIV testing in North Carolina

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel

Centers for Diseases Control and Prevention, C. Public Health Guidance for Community-Related Exposure

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

A c c e p t e d M a n u s c r i p t